glp 1 drugs pros and cons What should you do when a patient doesn't respond to a GLP-1? You've titrated the dose. You've optimized lifestyle support. They're adherent, motivated—and still, there is no expected weight loss. Before assuming GLP-1 Medications vs. Traditional Weight
Description
doi: 10.1152/ajpendo.1999.276.6.E1049

TZP was well tolerated as an add-on to oral glucose-lowering drugs monotherapy in Japanese diabetic participants and showed development in GC and BW, irrespective of undercurrent glucose-lowering drugs (82)

Healthcare organizations, such as the American Diabetes Association, also dont endorse microdosing

International Immunopharmacology

Rising disposable incomes, growing recognition of diabetes-related risks, and government efforts to enhance chronic disease management are expected to support substantial market growth for GLP-1 receptor agonists across Asia Pacific

[DOI] [PMC free article] [PubMed] [Google Scholar] 18.Johnson B., Milstead M., Green L., Kreider R., Jones R